[Form 4] Corcept Therapeutics Inc. Insider Trading Activity

Rhea-AI Filing Summary

Gillian M. Cannon, a director of Corcept Therapeutics Inc. (CORT), reported a donation of 7,393 shares of the issuer's common stock executed on 09/10/2025 under transaction code G(1). The filing shows the shares were donated to a Fidelity Charitable Giving Account and the reporting person’s beneficial ownership of common stock following the transaction is reported as 0 shares. The Form 4 was signed by an attorney-in-fact, Joseph Douglas Lyon, on 09/11/2025. The filing includes a remark that the power of attorney is on file with the SEC.

Positive

• Clear disclosure of a charitable donation of 7,393 shares with transaction code G(1)
• Post-transaction beneficial ownership is explicitly reported as 0 shares, eliminating ambiguity
• Power of attorney and signature are documented, indicating procedural compliance

Negative

• Reduction to zero beneficial ownership may be notable for investors tracking insider holdings

Insights

Corporate Governance Expert

TL;DR Director reported a charitable donation that reduced her reported holdings to zero; procedural filing appears routine.

The transaction was coded G(1), indicating a bona fide gift to a charitable account, and the filer discloses the power of attorney used to execute the Form 4. From a governance perspective, the disclosure meets Section 16 reporting requirements by reporting the donor, the amount gifted, and the post-transaction beneficial ownership. There is no indication of an associated sale or compensation transaction in this filing.

Securities Analyst

TL;DR Insider donated 7,393 shares; the report is informational and shows no sale or exercise activity.

As reported, the disposition was a donation rather than a market transaction, so there is no direct cash flow impact to the issuer. The filing discloses the exact share count and that the recipient is a Fidelity Charitable account. The timing and form execution are documented, suggesting standard compliance with reporting procedures. No additional transactions or derivative positions are reported.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cannon Gillian

(Last) (First) (Middle)

C/O CORCEPT THERAPEUTICS INCORPORATED

101 REDWOOD SHORES PARKWAY

(Street)

REDWOOD CITY CA 94065

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CORCEPT THERAPEUTICS INC [ CORT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/10/2025		G(1)		7,393	D	$0.00	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a donation by the Reporting Person to Fidelity Charitable Giving Account.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.

	/s/ Joseph Douglas Lyon, as attorney-in-fact for Gillian M. Cannon.	09/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Gillian M. Cannon report on Form 4 for CORT?

She reported a donation of 7,393 shares of Corcept Therapeutics common stock on 09/10/2025 to a Fidelity Charitable Giving Account.

How many CORT shares does the reporting person own after the transaction?

The Form 4 shows 0 shares of beneficial ownership following the reported transaction.

What does transaction code G(1) mean in this Form 4?

In this filing, code G(1) is used to indicate the reported disposition was a gift to a charitable account; the filer explicitly states it was a donation to Fidelity Charitable.

Who signed the Form 4 for Gillian M. Cannon?

The Form 4 was signed by Joseph Douglas Lyon as attorney-in-fact on 09/11/2025, and the power of attorney is on file with the SEC.

Does the Form 4 report any option exercises or derivative transactions for CORT?

No. Table II (derivative securities) shows no entries; only the non-derivative donation is reported.